Community Research Advisors Group (CRAG)
By
Treatment Action Group,
Community Research Advisors Group (CRAG)
Published: May 6, 2021, 10:37 p.m.·
Tags:
Drug-susceptible TB,
Treatment
A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.
Read More →
By
Community Research Advisors Group (CRAG)
Published: July 1, 2018, 5:20 p.m.·
Tags:
HIV coinfection,
Prevention
Have you heard?? ACTG 5279: One-month TB prophylaxis as effective as nine-month regimen for people living with HIV
Read More →
By
Community Research Advisors Group (CRAG)
Published: Jan. 15, 2018, 7:08 p.m.·
Tags:
Scientific research,
Advocacy
January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical research of high public health relevance and is key to strengthening domestic and global campaigns to eliminate TB. TBTC studies have produced several notable breakthroughs, including a shorter regimen for preventing TB (3HP) using isoniazid and rifapentine. The Community Research Advisors Group (CRAG) produced this briefing document to raise awareness of the TBTC’s legacy of accomplishments; highlight major advances in TB care resulting from TBTC studies; and make the case for increasing funding for TB research at CDC in line with the goals of the U.S. National Action Plan for Combatting Multidrug-Resistant Tuberculosis.
Read More →
By
Community Research Advisors Group (CRAG)
Published: Feb. 21, 2016, 7:33 p.m.·
Tags:
Access,
Advocacy,
CRAG
The Community Research Advisors Group urges Sanofi to submit a bid for rifapentine to be included in the Stop TB Partnership's Global Drug Facility catalogue.
Read More →
By
Community Research Advisors Group (CRAG),
TB CAB,
civil society organizations
Published: March 11, 2015, 4:31 p.m.·
Tags:
Global TB response,
Advocacy
An open letter requests that The Union take steps to retire the use of stigmatizing and criminalizing terminology from the papers published in its journals and the abstracts submitted to its conferences.
Read More →
By
Community Research Advisors Group (CRAG)
Published: Jan. 7, 2015, 10:55 p.m.·
Tags:
CRAG,
Advocacy,
Scientific research
The document is designed to facilitate community reviews of clinical trials protocols and to ensure community participation in protocol development.
Read More →
By
ATAC,
Community Research Advisors Group (CRAG),
European AIDS Treatment Group (EATG),
TB CAB
Published: Aug. 1, 2014, 9:25 p.m.·
Tags:
Advocacy,
TB CAB,
CRAG
Several community groups express concerns regarding the STREAM stage II trial design for bedaquiline approval.
Read More →
By
TB CAB,
Community Research Advisors Group (CRAG),
Treatment Action Group
Published: Feb. 13, 2014, 12:54 p.m.·
Tags:
Advocacy,
Pharma industry,
Research and development
Community groups express concern for AstraZeneca's departure from tuberculosis and urge the company to ensure continued investment in the field.
Read More →
Page 1 of 2 · Total posts: 10
1
2
Last→